Presentation is loading. Please wait.

Presentation is loading. Please wait.

Treatment of cutaneous pseudolymphoma with interferon alfa-2b

Published byLogan Burke Modified over 5 years ago

Similar presentations

Presentation on theme: "Treatment of cutaneous pseudolymphoma with interferon alfa-2b"— Presentation transcript:

1 Treatment of cutaneous pseudolymphoma with interferon alfa-2b
Sanjay Tomar, MD, Howard L. Stoll, MD, Marcelle A. Grassi, MD, Richard Cheney, MD  Journal of the American Academy of Dermatology  Volume 60, Issue 1, Pages (January 2009) DOI: /j.jaad Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Skin lesions of pseudolymphoma on the back.
Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

3 Fig 2 Low-power image showing a dense superficial and deep perivascular lymphotic infiltrate. No dermal mucin or interface change is identified. (Hematoxylin–eosin stain; original magnification: ×2.) Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

4 Fig 3 Deep perivascular lymphocytic aggregate with well developed germinal center and a mantle of small- to medium-sized lymphocytes. (Hematoxylin–eosin stain; original magnification: ×20.) Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

5 Fig 4 Resolution of the skin lesions after treatment with intralesional interferon alfa-2b. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

Download ppt "Treatment of cutaneous pseudolymphoma with interferon alfa-2b"

Similar presentations

Steven Q. Wang, MD, Leonard H. Goldberg, MD, FRCP 

Steven Q. Wang, MD, Leonard H. Goldberg, MD, FRCP 
Cutaneous polyarteritis nodosa presenting as a solitary blue toe

Cutaneous polyarteritis nodosa presenting as a solitary blue toe
Refractory cutaneous lichenoid sarcoidosis treated with tranilast

Refractory cutaneous lichenoid sarcoidosis treated with tranilast
Volume 4, Issue 1, Pages (January 2018)

Volume 4, Issue 1, Pages (January 2018)
CD47 expression for in situ and invasive cutaneous epithelial lesions

CD47 expression for in situ and invasive cutaneous epithelial lesions
Sclerodermiform linear lupus erythematosus: A distinct entity or coexistence of two autoimmune diseases?  Marc Julià, MD, Jose M. Mascaró, MD, Antonio.

Sclerodermiform linear lupus erythematosus: A distinct entity or coexistence of two autoimmune diseases?  Marc Julià, MD, Jose M. Mascaró, MD, Antonio.
Evaluation of skin atrophy associated with linear atrophoderma of Moulin by ultrasound imaging  Osamu Norisugi, MD, Teruhiko Makino, MD, PhD, Hiroshi.

Evaluation of skin atrophy associated with linear atrophoderma of Moulin by ultrasound imaging  Osamu Norisugi, MD, Teruhiko Makino, MD, PhD, Hiroshi.
Cutaneous vasculitis in two patients taking an herbal supplement containing black cohosh  Adam Ingraffea, BA, Kevin Donohue, MD, Caroline Wilkel, MD,

Cutaneous vasculitis in two patients taking an herbal supplement containing black cohosh  Adam Ingraffea, BA, Kevin Donohue, MD, Caroline Wilkel, MD,
Accuracy of biopsy sampling for subtyping basal cell carcinoma

Accuracy of biopsy sampling for subtyping basal cell carcinoma
Ibrutinib-associated pityriasis rosea–like rash

Ibrutinib-associated pityriasis rosea–like rash
Allison Hanlon, MD, PhD, June Kim, MD, David J. Leffell, MD 

Allison Hanlon, MD, PhD, June Kim, MD, David J. Leffell, MD 
Diffuse hyperpigmented plaques as cutaneous manifestation of multicentric Castleman disease and treatment with thalidomide: Report of three cases  Xiaoqing.

Diffuse hyperpigmented plaques as cutaneous manifestation of multicentric Castleman disease and treatment with thalidomide: Report of three cases  Xiaoqing.
Aggressive cutaneous infection with Mycobacterium marinum in two patients receiving anti–tumor necrosis factor-alfa agents  Julie Caron, MD, Carine Michot,

Aggressive cutaneous infection with Mycobacterium marinum in two patients receiving anti–tumor necrosis factor-alfa agents  Julie Caron, MD, Carine Michot,
CME examination Journal of the American Academy of Dermatology

CME examination Journal of the American Academy of Dermatology
Expression of PD-L1 in mastocytosis

Expression of PD-L1 in mastocytosis
Array of cutaneous adverse effects associated with sorafenib

Array of cutaneous adverse effects associated with sorafenib
Subcutaneous sarcoidosis: Is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease?  Iftikhar Ahmed, MD, Sujata R.

Subcutaneous sarcoidosis: Is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease?  Iftikhar Ahmed, MD, Sujata R.
Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin  Jennifer Lin, MD, Jason P.

Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin  Jennifer Lin, MD, Jason P.
Peter C. Schalock, MD, Jeoffrey B. Brennick, MD, James G. H

Peter C. Schalock, MD, Jeoffrey B. Brennick, MD, James G. H
Stephanie M. Gallitano, MD, Alessandra Haskin, BA  JAAD Case Reports 

Stephanie M. Gallitano, MD, Alessandra Haskin, BA  JAAD Case Reports 

Similar presentations

Ads by Google